Remote Rare Disease Key Account Leader

Amgen; Oregon; Hybrid; USD 173,000 - 234,000; Full time

Benefits offered by this job

Retirement and Savings Plan

Stock-based long-term incentives

Flexible remote work arrangements

Annual bonus program

Job summary

Amgen seeks a Rare Disease Key Account Manager to reduce time to diagnosis, improve patient access, and drive therapy uptake in targeted health systems and clinics. You will partner with clinical leaders, pharmacists, and administration to align strategies across networks.

The role emphasizes buy-and-bill optimization, contract negotiations, and cross-functional leadership to strengthen patient and site readiness and ensure compliant, efficient access to Amgen therapies.

Qualifications

• Doctorate degree and 2 years of sales/account management experience or equivalent.
• Experience with complex provider accounts, health systems, or infusion centers.
• Knowledge of reimbursement, contracting, and site-of-care considerations.
• Executive communication and cross-functional collaboration skills.

Responsibilities

• Identify barriers to therapy access and lead account plans with stakeholders.
• Coordinate contracting, pricing, and reimbursement activities for assigned accounts.
• Optimize buy-and-bill workflows and site readiness across care sites.
• Provide timely field insights and track account performance against objectives.

Skills

Executive communication

Problem solving

Stakeholder influence

Strategic thinking

Education

Doctorate degree

Master’s degree

Bachelor’s degree

Associate’s degree

High School diploma

Job description

Amgen seeks a Rare Disease Key Account Manager to reduce time to diagnosis, improve patient access, and drive therapy uptake in targeted health systems and clinics. You will partner with clinical leaders, pharmacists, and administration to align strategies across networks.

The role emphasizes buy-and-bill optimization, contract negotiations, and cross-functional leadership to strengthen patient and site readiness and ensure compliant, efficient access to Amgen therapies.